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Candida albicans is an important human pathogen, causing opportunistic infections.
The adhesion of planktonic cells to a substrate is the first step for biofilm development.
The antimicrobial peptide (AMP) Psd1 is a defensin isolated from Pisum sativum
seeds. We tested the effects of this AMP on C. albicans biofilms and planktonic cells,
comparing its activity with amphotericin B and fluconazole. Three C. albicans variants
were studied, one of them a mutant deficient in glucosylceramide synthase, conferring
resistance to Psd1 antifungal action. Atomic force microscopy (AFM) was used to assess
morphological and biomechanical changes on fungal cells. Surface alterations, with
membrane disruption and leakage of cellular contents, were observed. Cytometry assays
and confocal microscopy imaging showed that Psd1 causes cell death, in a time and
concentration-dependent manner. These results demonstrate Psd1 pleiotropic action
against a relevant fungal human pathogen, suggesting its use as natural antimycotic
agent.
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INTRODUCTION
Candida albicans is an opportunistic human pathogen, causing oral, genital and systemic fungal
infections, which are especially relevant among immunocompromised patients (Berman and
Sudbery, 2002). Despite the available antifungal therapies, mortality and morbidity caused by this
pathogen are still high (Behnsen et al., 2008). Candidiasis associated with intravenous lines and
bioprosthetic devices is problematic, since these devices can act as substrates for biofilm growth.
The presence of biofilms can result in serious problems due to their resistance to antimicrobial
agents. This resistance is developed by the presence of quorum-sensing molecules that plays an
important role in the biofilm formation and virulence, based on the local density of the fungal
population present for the construction and/or dissolution of biofilm communities (Donlan, 2002;
Kruppa, 2009; Deveau and Hogan, 2011). There is a thin line between free-floating planktonic
cells and biofilm growth. In fact, biofilm development begins when planktonic cells adhere to
the substrate. Adhered/adherent cells grow and divide, creating a protective matrix including
secreted exopolysaccharides (EPSs) (Donlan, 2002; Kruppa, 2009; Deveau and Hogan, 2011).
EPSs contribute to the volume of a biofilm, and for its slimy macroscopic properties. A fully
developed biofilm is highly structured, with layers of cells rising up and permeated by fluid-
filled microchannels (Donlan, 2002). These dynamic communities can spread across surfaces,
incorporate particulates and other microbes from the surrounding environment, and continually
shed new planktonic cells (Stephens, 2002). C. albicans has the ability to attach, colonize, and form
biofilms on a variety of surfaces. The importance of C. albicans as a pathogen has led to a significant
effort on the development of new strategies to control and detect the disease (Srinivasan et al., 2011).
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Fungi possess a unique cell wall and cell membrane that
can serve as targets for antifungal agents. The fungal cell
membrane is similar to other eukaryotic cells, composed of a
lipid bilayer with proteins embedded within it, having ergosterol
as its main sterol (Katzung et al., 2011). Glycosphingolipids
(GSL) are a family of lipids that act as key components of
biological membranes in animals, plants and fungi (Leipelt et al.,
2001; Halter et al., 2007; Daniotti and Iglesias-Bartolome, 2011).
The most common GSL found in fungi is glucosylceramide
(GlcCer), present in the cell membrane of most fungi, such as
Pichia pastoris, C. albicans, Cryptococcus neoformans, Aspergillus
fumigatus, Sporothrix schenckii, and Neurospora crassa (Barreto-
Bergter et al., 2004; Saito et al., 2006). Large amounts of this
glycosphingolipid have also been found in the fungal cell wall
(Nimrichter and Rodrigues, 2011). Its functions during fungal
growth/dimorphism have been correlated with the virulence
process (Rittershaus et al., 2006), suggesting GSL as potential
targets on the development of new antifungal drugs (Rittershaus
et al., 2006; Nimrichter and Rodrigues, 2011; Gonçalves et al.,
2012).
Antimicrobial peptides (AMPs) are cationic molecules
characterized by short sequences (usually 15–50 amino acid
residues), which possess both hydrophobic and hydrophilic
residues, resulting in amphipathic structures. Endogenous AMPs
from plant, fungal or animal origin are produced in order to
protect themselves from pathogenic microbes. This adaptive
mechanism makes them essential to the innate immune system.
AMPs therapeutic activity unfolds against bacteria, fungi,
protozoan and metazoan parasites, viruses, skin diseases and
tumor cells (Li et al., 2012; Morizane and Gallo, 2012; Torrent
et al., 2012). Extensive information on their therapeutic activity
and mode of action has been given elsewhere (Silva et al., 2014).
These natural antibiotics have the additional advantage of not
being prone to the development of antibiotic-resistant microbial
strains (Korting et al., 2012).
Psd1 is a cysteine-rich 46 amino acid residues defensin,
isolated from the seeds of the garden pea (Pisum sativum)
(Almeida et al., 2000, 2002; Cabral et al., 2003; de Medeiros et al.,
2010). It is found primarily in epidermal tissues and vascular
bundles of pea pods. This peptide exhibits high antimicrobial
activity against several filamentous fungi and the dimorphic C.
albicans and N. crassa, but not against several tested bacteria
(Almeida et al., 2000, 2002; Lobo et al., 2007; de Medeiros et al.,
2010). Psd1 at 20 µM has been shown to cause a 100% growth
inhibition of C. albicans wild type (WT), while having a 70%
inhibition of its corresponding C. albicans gcs-deleted strain
(1gcs) (de Medeiros et al., 2014). Recently, we demonstrated
through membrane partition studies that Psd1 has high affinity
and specificity for membranes with ergosterol and GlcCer, as
in fungal cells (Gonçalves et al., 2012). On the contrary, this
defensin has a low interaction with cholesterol-rich membranes,
explaining the reduced toxicity of Psd1 to human cells (Gonçalves
et al., 2012). A lack of Psd1 internalization in C. albicans
mutant strain (1gcs) has been shown by confocal microcopy
(de Medeiros et al., 2014). Together, these results indicated that
GlcCer is important for Psd1 interaction with the fungal plasma
membrane, as well as for its internalization.
In the present study, the mode of action of Psd1 was assessed
through the evaluation at the nanoscale level of its effects on
the cell morphology, roughness and stiffness of three different
Candida albicans strains. Differences between planktonic cells
and biofilms were found for the variants studied. Confocal
microscopy and atomic force microscopy (AFM) images of
untreated and treated C. albicans cells showed that Psd1 kills
planktonic cells at 20 µM, while total inhibition and partial
eradication of biofilm were only observed at a 10-fold higher
concentration. The C. albicans 1gcs mutant showed alterations
in cell morphology and roughness even in the absence of
the peptide, both for biofilms and planktonic cells. In the
presence of Psd1, adherence of planktonic cells was decreased
and a total inhibition and/or eradication of the biofilm were
observed. These results demonstrate several key aspects for
Psd1-fungal membrane interaction, for which GlcCer is highly
relevant. Additionally, our data indicates that the defensin
has a pleiotropic action, with an additional component of its
antimicrobial action occurring intracellularly.
MATERIALS AND METHODS
Candida albicans Cultures Preparation
Three C. albicans strains were studied: a clinical isolate (CI)
collected from a patient at the Santa Maria Hospital (Lisbon,
Portugal), SC5314/ATCC MYA-2876 (WT) and SC5314 CAI4
ura31::imm434/ura31::imm434 (1gcs), congenic to SC5314,
kindly provided by Dr. Dirk Warnecke (Institut fur Allgemeine
Botanik, University of Hamburg, Germany). On 1gcs, the
glucosylceramide synthase gene (HSX11) was disrupted, making
the strain deficient on glucosylceramide lipid (Leipelt et al., 2001).
Strains stocks were kept at −80◦C, with 15% glycerol. Cells in
stock, previously thawed, were inoculated onto Yeast Peptone
Dextrose (YPD, Sigma Aldrich, USA) agar plates, and incubated
for 48 h at 37◦C. After this period, an isolated fungal colony
was cultured overnight at 25◦C with shaking at 180 rpm in
YPD broth. During this period, the culture reaches the stationary
phase of growth. Cells were harvested by centrifugation at 1,880 g
for 10 min at 4◦C, the supernatant was removed and cells
were washed three times with 10 mM HEPES buffer pH 7.4
with 150 mM NaCl, for planktonic studies, and with 10 mM
phosphate buffered saline (PBS, 2.7 mM potassium chloride, 137
mM sodium chloride) pH 7.4 for biofilm assays. Afterwards, cell
concentration was determined and the initial suspension was
diluted to the concentration necessary for each experiment.
Susceptibility of Planktonic C. albicans to
Amphotericin B, Fluconazole and Psd1
In vitro antifungal susceptibility tests were performed to
determine the minimal inhibitory concentration (MIC). It
was determined according to recommendation of the National
Committee for Clinical Laboratory Standards (National
Committee for Clinical Laboratory Standard, 1997), by the
microdilution method, in 96-well microplates (Brito et al., 2010;
Eksi et al., 2013). RPMI 1640 medium with L-glutamine (Gibco-
Life Technologies, UK) was used, supplemented with 0.2%
glucose, 165 mM MOPS (3-morpholinopropanesulfonic acid)
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(AppliChem, Germany) and buffered to pH 7.4. For the sake of
comparison and as positive control, the conventional antifungal
drugs amphotericin B (AMPH B) and fluconazole (FCZ) (Sigma
Aldrich, USA) were also tested against the selected strains. Each
well was prepared to a total volume of 200 µl, with the growth
medium (RPMI), different AMPH B or FCZ concentrations
(0.001 to 100 µg/ml) and C. albicans (2× 103 cells/ml). Controls
without antifungal were also tested. Plates were incubated for
48 h at 37◦C, after which optical density was measured at 540
nm. MIC was defined as the minimal concentration of a drug
that, after incubation, causes 100% growth inhibition of an
organism (Andrews, 2001). Experiments were performed in
triplicate and values were analyzed with GraphPad Prism 5,
using the Gompertz equation for MIC determination (Lambert
and Pearson, 2000). Experiments with Psd1 were performed at
90 µg/ml (20 µM) (de Medeiros et al., 2014).
Biofilm Development and XTT/Menadione
Testing Assay
The formation and susceptibilities of C. albicans biofilms were
determined by 96well-plate basedmethod (Pierce et al., 2008). To
determine the optimal cell concentration for biofilm formation
for each strain, 100 µl C. albicans suspension cells in RPMI 1640
with glucose 2% and 165 mM MOPS, at 1.0 × 105, 1.0 × 106,
1.0 × 107, and 1.0 × 108 cells/ml were placed on a polystyrene
96 well plate, each sample in triplicate. Plates were incubated for
12, 24, 48, 72, and 96 h at 37◦C, in order to establish the optimal
cell concentration for biofilm development. At the end of each
step-time (incubation time), the biofilm was washed three times
with PBS to remove planktonic and/or no adherent cells. At this
point, 100µl of XTT/menadione solution (1µl menadione 1mM
in 10 ml XTT 0.5 g/l) were added on each well-plate (where the
biofilm is formed) and incubated for 2 h at 37◦C. After this time,
an orange color reveals the metabolic activity of the cells within
the biofilm. The supernatants were transferred to a new plate and
the optical density measured at 490 nm.
Atomic Force Microscopy Imaging
Planktonic cells imaging were performed for all C. albicans
strains as follows, 1 × 105 cells/ml were incubated at 25◦C in
HEPES buffer, with agitation, for 6 and 24 h. AMPH B, FCZ,
and Psd1 final concentrations were equal to the MIC and 10-
fold higher than the MIC. As a control, cells without antifungal
treatment were used. A 100 µl droplet of each test sample was
applied onto a poly-L-lysine (PLL)-coated coverslip and left at
25◦C for 2 h. After deposition, the samples were rinsed 10 times
with filtered (0.2 µm) deionized water and air-dried at 25◦C.
Untreated and treated cells were imaged using a JPK
NanoWizard II atomic force microscope (JPK Instruments,
Berlin, Germany) mounted on a Zeiss Axiovert 200 inverted
microscope (Carl Zeiss MicroImaging, Jena, Germany).
Measurements were carried out in intermittent contact mode,
at room temperature, using uncoated silicon ACL cantilevers
(Applied NanoStructures, Mountain View, CA, USA). These
cantilevers have typical resonance frequencies of 145–230 kHz
and spring constants of 20-90 N/m. The scan rate was set to less
than 1 Hz for imaging and image resolution was set to 512 ×
512 pixel for all images. Height, error signal and phase contrast
images were recorded, and line-fitted as required. From recorded
images, height and size information was obtained with the JPK
Data Processing software v.4.2.53.
Roughness analysis of AFM height images was performed
using the Gwyddion 2.31 software (Czech Metrology Institute,
Brno, Czech Republic). Roughness was calculated from the
root mean square value (RMS, i.e., standard deviation of the
distribution of heights over a 1× 1µm2 imaged area). The results
of this processing were statistically analyzed using analysis of
variances (ANOVA) and Bonferroni post-tests.
AFM-Based Cell Stiffness Measurements
C. albicans washed suspensions were incubated at room
temperature, with agitation, for 24 h. AMPH B, FCZ, and Psd1
final concentrations were 10-fold higher than the MIC. Final cell
concentration was 1 × 105 cells/ml and as control, cell samples
were incubated without any treatment. 100 µl of each sample
were placed onto a poly-L-lysine (PLL)-coated glass coverslip
and left at 25◦C for 2 h. After deposition, samples were rinsed
10 times with HEPES buffer to remove any cells that had not
adhered to the coverslip. 100 µl of HEPES buffer were added
to the adhered cells to avoid sample drying. Measurements
were carried out in HEPES buffer at 25◦C, using 200 µm long
gold reflex coated silicon-nitride OMCL-TR400PSA-1 cantilevers
(Olympus, Japan). These cantilevers have typical resonance
frequencies of 8–14 kHz and spring constants of approximately
0.02N/m.
First, to have a prior overview of the cells shape and height,
force maps were performed using a 10 µm/s approach and
retraction speed, Z length of 3 µm and a relative set-point
of 0.4 V. The coordinates on the map were then chosen.
Afterwards, one location per each cell was chosen and force-
distance measurements were conducted over those coordinates,
in triplicate, using a 3 µm/s approach and retraction speed, Z
length of 3 µm and a relative set-point of 0.4 V. These conditions
ensure that the identation ranged from 5 to 10% of cells height.
Retraction force-distance curves were processed with the JPK
Data Processing software v. 4.2.53. After processing, the four-
sided pyramid Hertz modified equation was applied to the curves
and the Young’s modulus obtained. The results of this processing
were statistically analyzed using ANOVA and Bonferroni post-
tests.
Biofilm Inhibition and Eradication Assays
Biofilm inhibition and eradication assays were determined by
using the cells conditions obtained in biofilm development
assays. Once the cells concentrations for each strain were
determined, concentrations of AMPH B, FCZ, and Psd1 used
for biofilm inhibition and eradication assays correspond to 10
and 100-fold higher than the MIC. In inhibition assays, the
antifungal drugs were placed at the same time than cells (pre-
mixing antifungal with cells) and incubated during the same
step-time previously determined for biofilm development. For
eradication assays, antifungals were added once the biofilm was
formed, for each strain, and left to incubate for 24 h at 37◦C.
In both cases, biofilms medium were replaced with PBS for
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microscopy measurements. For AFM imaging, biofilms were
washed 10 times with filtered deionized water (0.2 µm) and
air-dried at room temperature. Biofilm images for formation,
inhibition and eradication of C. albicans strains were measured
directly on the surface where cells were grown.
Live/Dead Measurements of Biofilms and
Plancktonic Cells by Confocal Microscopy
and Flow Cytometry
Live/Dead assay kit was used both on C. albicans biofilms and
plancktonic cells. LIVE/DEAD R© FungaLightTM Yeast Viability
Kit (L34952, LifeTechnologies, USA) is composed by two
fluorescent probes, SYTO 9 and propidium iodide (PI). In a
population of live and dead cells, SYTO 9 nucleic acid labels all
yeast in a population, those with intact membranes and those
with damaged membranes. In contrast, PI penetrates only yeast
with damaged membranes, causing a reduction in the SYTO
9 stain fluorescence by fluorescence resonance energy transfer
(FRET) when both dyes are present (Johnson and Spence, 2010).
As a result, yeast with intact membranes is stained with green
fluorescence, whereas yeast with damaged membranes is stained
with red fluorescence.
Optical microscopy experiments with a Zeiss LSM 510
META confocal point-scanning microscope (Jena, Germany)
were carried out in order to examine the architecture and the
viability of the cells before and after exposure to antifungal
agents. Argon (488 nm; 45 mW) and diode-pumped solid-state
(561 nm; 15 mW) lasers were used with a 40 × dry-objective.
Cells were incubated with AMPHB (10mg/ml), FCZ (40mg/ml),
or Psd1 (900 µg/ml) for 24 h prior to imaging. These antifungal
concentrations were selected to be 10 times more than the
planktonic MIC. Afterwards, biofilms were labeled with SYTO 9
and PI probes, incubated for 15 min and images acquired. Images
were analyzed with ImageJ 1.47v (rsbweb.nih.gov/ij/).
For flow cytometry assays, C. albicans strains were incubated
for 24 h with AMPH B, FCZ, and Psd1 with antifungal
concentration equal to the planktonic MIC and 10-folder
higher. The double labeled cells were considered as positive
result for death, since the green dye is present in all cells,
and besides the FRET phenomena, the green fluorescence
intensity had always a small contribution. C. albicans stains
were performed according to the manufacturer’s instructions.
Briefly, 1 × 105 cells/ml in HEPES buffer were stained
with both dyes to a final concentration of 3.34 and 20 µM
(SYTO 9 and PI, respectively). All samples were kept at room
temperature in the dark for 15 min before flow cytometry
analysis. Experiments were performed in a BD Accuri C6
Flow Cytometer (BD Biosciences, San Jose, CA, USA), using
blue (488 nm) and red (640 nm) lasers to excite stained cells.
Green fluorescence emission was detected with a 530 nm
bandpass filter and red fluorescence emission was detected
with a 670 nm bandpass filter. Fluorescence emission was
acquired in bioexponential scale, and data were collected for
40 000 cells. All flow cytometer results were analyzed using
FlowJo Software version 10.0x (Tree Star Inc., Ashland, OR,
USA).
RESULTS
Susceptibility of Planktonic C. albicans to
AMPH B, FCZ, and Psd1
The activity of AMPH B and FCZ against the three C. albicans
strains was determined by measuring their susceptibility to
the antifungal drugs, as shown in Figure S1 (Supplementary
Material). The obtained curves were fitted and MIC values were
obtained using the Gompertz equation (Lambert and Pearson,
2000). The values used for Psd1 were reported in previous works
(20 µM) (de Medeiros et al., 2014). As shown in Figure S1, MIC
values for AMPH B and FCZ differed depending on the strain
studied. Altogether, the three C. albicans strains were sensitive to
AMPHB, FCZ, and Psd1. AMPHB and FCZ showed similarMIC
in WT and ∆gcs planktonic cells (these four MICs are all on the
3.7–4.0 µg/ml range). Lower values were obtained when CI was
tested.
Biofilm Development and XTT/Menadione
Testing Assay
Biofilm formation is dependent of cellular adherence to the
growth surface. To study the mode of action of Psd1 on C.
albicans biofilm formation, polystyrene surfaces were selected.
To optimize the conditions for biofilm formation, XTT assays
were performed for the three C. albicans strains studied. The time
and the cell concentrations that ensure the best biofilm growth
are shown in Figure S2 (Supplementary Material). As it can be
seen, the cell density needed for biofilm development differs from
strain to strain. WT and 1gcs need a cell concentration 10-fold
higher than the CI (105 cells/ml) to initiate biofilm development.
Despite this, the clinical isolate andWT formed biofilm after 24 h,
while themutant strain needs 72 h to ensure biofilm development
and adherence.
AMPH B, FCZ, and Psd1 Cause
Morphological Alterations in C. albicans
Plancktonic Cells
AFM imaging on intermittent contact mode was used to evaluate
the effects suffered by C. albicans planktonic cells after 6 h
and 24 h of incubation with AMPH B, FCZ or Psd1 at the
MIC and at 10-fold higher concentrations. The error signal
is the difference between the detector signal and the setpoint,
and provides images with greater spatial detail. In general,
antimicrobial treatments induced morphological changes in all
cells. The severity of these effects increased in a time-dependent
manner. After 6 h, it was possible to observe small irregularities
in the cell surface (blebs) and small vesicles deposited over
and around the cells at 10-fold higher than the MIC antifungal
concentration (data not shown). As seen in Figure 1 for CI and
WT strains, untreated cells (controls) have a smooth surface
and regular shape (Figures 1A,D). In contrast with CI and
WT, untreated 1gcs cells showed irregular surface (Figure 1G).
The incubation for 24 h with Psd1 at MIC concentration
showed some deformations at cell surface (Figures 1B,E,H). At
10 × MIC enhanced effects than those obtained at MIC were
observed (Figures 1C,F,I). Small blebs are being released from
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the cells accompanied and internal content released (Figure 1
and Figure S7).
Unlike AMPH B and FCZ (Figures S5, S6), Psd1 effects appear
to be more severe. The consensual outcome is the release of
the cell internal content or cells completely covered by blebs.
For WT treated cells, the height of a bleb is approximately 14
nm (Figure S3). Blebs accumulate over each other, forming a
bulk structure on top of the cell. Similar results were obtained
for mutant cells (Figure S4). Only for CI cells a peel-off-like
morphology was observed at Psd1 10 × MIC (Figure 1C). Of
the three treatments, AMPH B is the one that induced a more
extensive cell deformation: cells lose volume and membranes
appear rougher. The clinical isolate seems to be less affected by
FCZ, at both times of incubation and concentration of drug used,
only with some irregularities in the cell surface appearing after
24 h of incubation.
C. albicans Suffers an Increase in Surface
Roughness after Treatment with AMPH B,
FCZ, or Psd1
Surface roughness was evaluated for the three C. albicans strains
before and after treatment with AMPH B, FCZ, and Psd1
(Figure 2), both after 6 h and 24 h of cell treatment. There
was an overall increase of the average roughness upon any
of the treatments performed with the planktonic cells. These
results, obtained with the RMS formula applied to 1 × 1
µm2 images of the surface of the cells, are in agreement with
the previous qualitative observations that surface roughness
increases after antifungal treatment (Figure 1). Regarding the
control conditions, CI andWT cells have lower surface roughness
values (Figures 2A,D, control), below 5 nm, whereas 1gcs
cells present surface roughness values above 5 nm (Figure 2G,
control). WT cells were the most affected (Figures 2D–F)
and 1gcs the least affected (Figures 2G–I) by any of the
treatments. All treatments with AMPH B caused a statistically
significant increase of membrane roughness on CI and WT cells
(Figures 2A,D). This was not always the case for 1gcs cells,
as their increase in roughness was not statistically significant
(Figures 2H,I). When comparing the three cells treated with
FCZ (Figures 2B,E,H), less effects on surface roughness were
observed for CI and 1gcs. On the contrary, WT cells were
strongly affected by this treatment and all conditions tested
resulted in a statistically significant increase in surface roughness.
Finally, Psd1 increased CI cells roughness in a way similar to
AMPH B (Figure 2C), whereas for WT cells the effects of Psd1
(Figure 2F) were similar in magnitude to those of FCZ. Again,
as it was observed for AMPH B and FCZ, 1gcs were the least
affected by Psd1; yet, the defensin was able to strongly increase
the surface roughness of these cells after 24 h of incubation, with
a peptide concentration 10-fold higher than the MIC (Figure 2I).
C. albicans Loses Stiffness after Treatment
with AMPH B, FCZ, or Psd1
Changes in the stiffness of the cells were assessed in two different
ways. One was based on the determination of the Young’s
modulus of the membrane, using AFM-based force spectroscopy
(for the three treatments; Figure 3); and the other was based in
the observation of AFM phase-contrast images of the cell surface,
which allow to visualize and distinguish softer and stiffer areas in
the membrane (for Psd1 only; Figure S7).
Young’s modulus determination was performed after 24 h of
incubation with an AMPH B, FCZ or Psd1 concentration 10-fold
higher than the MIC (Figure 3). CI cells had a mean value of
membrane stiffness of 354 ± 14 kPa, WT had a mean value of
384± 14 kPa and 1gcs had a mean value of 315± 21 kPa. When
1gcs cells stiffness was compared with WT, there was an 18%
reduction (red asterisk in Figure 3; ∗p < 0.05). The percentages
of stiffness reduction relative to the control were calculated to
better understand the different impacts of each treatment (values
in the dark red box on the bottom of Figure 3). AMPH B effects
on cell stiffness were more severe for 1gcs cells, with a 60%
reduction of the cell initial stiffness (Figure 3). WT cells were
the less affected by this treatment, with a 23% reduction of
the initial stiffness. FCZ was the treatment with the least effect
on the three strains and its highest reduction on stiffness was
registered for the WT cells, where FCZ caused a reduction to
nearly half of the initial stiffness. From the three treatments,
Psd1 caused the largest reduction on CI (67%) and WT (57%)
cells stiffness, whereas for 1gcs cells this was the treatment
with a lower effect (34% stiffness reduction). In all cases, the
treatment with the antifungal drugs, including Psd1, lead to
statistically significant decreases on the cells stiffness (Figure 3;
p < 0.001).
By phase contrast imaging of C. albicans after Psd1 treatment,
it was possible to distinguish some changes related to sample
properties such as stiffness and softness (Magonov et al., 1997;
Martinez and Garcia, 2006; Garcia et al., 2007; Nie et al., 2011).
Phase contrast images of control cells of the three strains all
present a homogenous surface. For the three strains, the results
observed are roughly the same. Blebs in the cell surface caused
by the treatment with the peptide are softer than the surrounding
cell surface (Figure S7, phase contrast images in Supplementary
Material), and even when there are no blebs formed, these images
allow to distinguish softer and stiffer areas.
Psd1 Provoke Death in C. albicans
Planktonic Cells
Flow cytometry experiments were carried out in order to
determine if Psd1 kills planktonic C. albicans cells, by live/dead
staining. CI, WT, and 1gcs cells were incubated for 24 h with
a concentration of AMPH B, FCZ or Psd1 equal to the MIC
and 10-folder higher. The quadrants (unstained, live, dead and
double positive cells) were established for each strain using their
respective controls (data not shown).
Figure 4 shows the flow cytometry dot plots obtained for
CI, WT, and 1gcs planktonic cells after treatment with Psd1
at MIC and 10-folder higher. Here, Psd1 had less of an effect
on CI cells, with fewer cells dead in the presence of the
peptide (Figures 4A–C). For WT and 1gcs, the percentage of
dead cells increased to 70.6% and 23.8% in presence of Psd1
at MIC concentration, respectively. Curiously, when peptide
concentration was increased to 10-folder higher, the percentage
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FIGURE 1 | Effect of Psd1 concentration on C. albicans planktonic cells. AFM error signal images of clinical isolate (A–C), wild type (D–F) and 1gcs (G–I) cells after
24 h incubation with Psd1: (A,D,G) 0 µM (control); (B,E,H) at the MIC (20 µM) and (C,F,I) at a 10-fold higher concentration. All images are 10 × 10 µm2.
of dead cells seems to be similar for 1gcs cells (27.8%), but not
for WT cells (48.7%).
Comparing all these results with those obtained for AMPH
B and FCZ (Figures S8–S10), it is possible to infer that Psd1
had a stronger effect in WT and 1gcs cells (Figures 2E,F,H,I,
respectively) similar to AMPH B (Figures S9, S10). AMPHB and
FCZ antifungals had the same effect in CI cells: approximately
20% of cells were killed by their effect (Figures 4B,C, and Figure
S8). Psd1 and AMPH B had the same behavior in all three strains:
less cell death was induced in CI strain by antifungal action,
while increasing death was observed in WT and 1gcs cells. On
the contrary, FCZ showed less dead cells (less than 30%) in C.
albicans strains.
AFM imaging of C. albicans Biofilms
AFM was used for imaging the effect of AMPH B, FCZ, and
Psd1 on C. albicans biofilms after incubation for 24 h at a
concentration 10 times higher than the MIC for planktonic cells
(Figure 5). Inhibition of biofilm development was observed for
CI and WT strains when treated with AMPH B, FCZ or Psd1
(data not shown). The inhibition of biofilm development showed
absence of hyphae or pseudohyphae. Budding yeast cells in small
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FIGURE 2 | Cell roughness (RMS) measurements after incubation of the clinical isolate (A–C), wild type (D–F) and 1gcs (G–I) C. albicans strains with AMPH B
(A,D,G), FCZ (B,E,H), and Psd1 (C,F,I), at the MIC and at a 10-fold higher concentration. Measurements were obtained from AFM height images, on 1 × 1 µm2
crops over the cell (N = 10). Columns correspond to the mean ± standard deviation of three independent measurements for each cell on a total of 30 cells for each
experimental condition. Two-way ANOVA and Bonferroni post-test were performed (*p < 0.05; **p < 0.01; ***p < 0.001). Error bars indicate the SEM.
FIGURE 3 | Cell stiffness measurements (Young’s modulus calculated from the AFM force-distance curves) after 24 h incubation of C. albicans with AMPH B, FCZ,
and Psd1 (concentrations 10-fold the MIC). Measurements correspond to triplicate for each cell on a total of 30 cells for each experimental condition. Two-way
ANOVA and Bonferroni post-test were performed (*p < 0.05; **p < 0.01; ***p < 0.001). Error bars indicate the SEM.
groups (4–8 cells) were observed for all antifungal treatments.
In the presence of AMPH B, CI seems to be less affected when
compared to WT. Images of the CI biofilm (Figure 5B) show an
absence of both pseudohyphae and hyphae. The effect of AMPH
B was more evident on WT biofilm (Figure 5F): large deformed
cells together with cells of reduced size. Both for the CI and
WT, the presence of surface uncovered by the cells evidences
changes in the biofilm biomass upon AMPH B action. These
effects were more remarkable with FCZ and Psd1. The uncovered
surface area was increased and the loss of volume was observed
for CI and WT strains. FCZ at 10 × MIC induced a decrease
on cell volume and size (Figures 5C,G). Psd1 caused important
morphological changes on the cell surface. For the CI treated
with Psd1 at 10 × MIC, the appearing of blebs and the loss of
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FIGURE 4 | Flow cytometry dot plots of clinical isolate (A–C), wild type (D–F) and 1gcs (G–I) planktonic cells after treatment with Psd1. Cells stained with both dyes
after 24 h incubation with Psd1 at MIC concentration (20µM) (B,E,H) and 10-folder higher (200µM) (C,F,I), as well as in its absence (A,D,G, control).
cell volume were observed (Figure 5D). WT seemed to be less
affected by Psd1. Nevertheless, the appearing of small blebs can
be noticed (Figure 5H). The percentages of live and dead cells
were experimentally quantified (Table S1). As shown, AMPH B
is more effective on biofilm eradication, when compared to FCZ
and Psd1.
Live/Dead Cell Confocal Imaging of
C. albicans Biofilms–Inhibition and
Eradication Assays
To evaluate the viability of yeast cells before and after antifungal
treatments, confocal laser scanning microscopy images were
acquire in three biofilm “phases”: formation, inhibition and
eradication of the formed biofilm. As shown in Figure 6, the
biofilm formed for all strains presented a 3D architecture,
consisting of a network of hyphae and budding yeast cells
connected at several points. Upon quantification, it was shown
that the density of dead cells once the biofilm was formed
was low (approximately 10%) for all strains (Figures 6A,E,I).
For the inhibition assays, no cells growth was observed after
antifungal treatment. Our data indicate that AMPH B, FCZ,
and Psd1 inhibited biofilm formation by reducing the rate of its
development.
For eradication assays, once the biofilm was developed
for each strain the antifungal was added at concentration
of 10 × MIC, and incubated for 24h. The results obtained
show that the biofilm formed by 1gcs strain was completed
eradicated (Figure 6), contrary to CI (Figures 6B–D) and WT
(Figures 6F–H), where the architecture of the biofilm suffered
perceptible/noticeable changes and the amount of dead cells was
increased, especially for CI treated with AMPH B (Figure 6B)
and FCZ (Figure 6C), and for WT treated with AMPH B
(Figure 6F).
DISCUSSION
Some Candida spp. strains are becoming resistant to the most
common antifungal medications. In this sense, many efforts
have been made in order to create antimicrobial agents that
act along the immune system to eradicate the infection in vivo.
Psd1 is an AMP with antifungal effects against C. albicans.
In order to understand the mode of action of this peptide,
three C. albicans strains were studied, one of them, with a
mutation in the GlcCer synthase gene, as well as its wild type
counterpart. In summary, Psd1 caused important morphological
changes, namely at the cell surface, and cell death. Adherence
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FIGURE 5 | AFM error images of C. albicans strains eradication assays. Clinical isolate (A–D), wild type (E–H) and 1gcs (I), in the absence of AMPH B (B,F), FCZ
(C,G) and Psd1 (D,H) at 10 × MIC. No image of antifungal treatment of 1gcs biofilm with AMPH B, FCZ, and/or Psd1 is shown, as the peptide eradicates the formed
biofilm. All images are 15 × 15 µm2, except for (D,H,I), which are 10 × 10 µm2.
FIGURE 6 | Eradication assays. Confocal microscopy images of the C. albicans strains clinical isolate (A–D), wild type (E–H) and 1gcs (I–L), in the absence (A,E,I)
and presence of AMPH B (B,F,J), FCZ (C,G,K) or Psd1 (D,H,L), at a concentration 10-fold higher than the MIC.
assays of C. albicans mutant to abiotic surface enhanced the
importance of GlcCer in Psd1 antifungal activity through the
study of the strain deficient in GlcCer (Lobo et al., 2007).
In fact, some of the observations reported in this work are
compatible with these evidences that Psd1 effects rely on the
presence of this lipid in the membrane of C. albicans (Tyagi and
Malik, 2010a; de Medeiros et al., 2014; Rollin-Pinheiro et al.,
2016).
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AMPs have been tested for their ability to affect physical
properties of cells, such as morphology, size, height, roughness,
and stiffness (Canetta et al., 2006; Tyagi and Malik, 2010a,b; Kim
et al., 2011; Eaton et al., 2012; Alsteens et al., 2013a,b; El-Kirat-
Chatel et al., 2013; Formosa et al., 2013). Importantly, C. albicans
cell wall composition can also be changed upon antifungal
treatment, inclusively at the level of the expression of adhesion
proteins, therefore also affecting cell-cell interactions (El-Kirat-
Chatel et al., 2013; Formosa et al., 2013). Two non-peptidic
conventional antifungal agents (AMPHB and FCZ) and a natural
AMP (Psd1) cause morphological alterations in C. albicans
(Alviano et al., 1999). Ergosterol is an essential component of
the fungal cell membrane. Its direct binding (AMPH B) (Gray
et al., 2012) or the inhibition of its synthesis (FCZ) (Chang et al.,
2008, 2014) results in increased cellular permeability, causing
leakage of cellular contents. Changes observed for C. albicans
strains occurred at low antifungal concentration and in a short
incubation time: a decreased in cell volume, the appearance of
blebs or a peeling effect at the cell surface, the increase of its
roughness (Tyagi and Malik, 2010a,b) and a lower ability of cells
to adhere to each other (Alsteens et al., 2013a,b). These were
common features displayed by the action of AMPH B, FCZ,
and Psd1. As observed for Psd1 (Figure 4), a peeling-like surface
pattern seemed to be an effect frequently induced on C. albicans.
The results presented here are in agreement to the reported effects
induced in C. albicans cells by AMPH B, flucytosine (Kim et al.,
2011) and caspofungin (El-Kirat-Chatel et al., 2013; Formosa
et al., 2013; Hasim et al., 2016).
Among the most commonly accepted models that describes
the mode of action of AMPs (Silva et al., 2014), the carpet model
is the one that may better explain the effects that causes a larger
decrease in membrane homogeneity and, due to a detergent-
like micellization, a loss in membrane resistance (Chang et al.,
2008). A weakened membrane could suffer disruption, leading
to the leakage of cellular contents, explaining the volume loss
observed on some cells (Figure 4). By observing the error signal
images, it was also possible to notice that Psd1-treated cells did
not aggregate like the control cells, or even like AMPH B or
FCZ-treated cells. This may evidence that Psd1 has some effect
on cell-cell adhesion. This outcome may be explained by the
destabilization introduced in the cell wall by Psd1 (El-Kirat-
Chatel et al., 2013; Hasim et al., 2016) and by a possible detergent-
like action at the membrane level (Da Silva and Machado, 2012).
C. albicans planktonic cells presented a significant increase in
surface roughness after treatment with AMPH B, FCZ or Psd1.
Upon surface analysis of AFM height images (Tyagi and Malik,
2010a,b; Domingues et al., 2013; Franquelim et al., 2013), it was
possible to quantify the increase inmembrane roughness that had
been noticed on the error signal images. The fact that 1gcs cells
were less affected by these substances may be due to the fact that
they are already rougher (Figure 2G) than CI and WT strains,
even before treatment with AMPH B, FCZ or Psd1.
The morphological changes due to the action of external
agents may also be associated with alterations on cell rigidity
(El-Kirat-Chatel et al., 2013; Hasim et al., 2016). AFM-based
force spectroscopy measurements allowed the quantification of
cell elasticity through Young’s modulus calculation (Domingues
et al., 2013; El-Kirat-Chatel et al., 2013; Franquelim et al., 2013).
C. albicans loses stiffness after treatment with AMPH B, FCZ
or Psd1. 1gcs cells presented an 18% reduction of the average
cell stiffness, comparing to its WT counterpart (Figure 3). This
may be due to the lack of GlcCer (Thevissen et al., 2004,
2012; Nimrichter and Rodrigues, 2011). Ceramides are known to
increase membranes rigidity, stability and structural organization
of biological membranes (Sullan et al., 2009). When compared to
AMPH B or FCZ effects in cell surface stiffness reduction, Psd1
had a stronger effect, both on CI and onWT cells, with decreases
of 67% and 57% relative to the control sample, respectively
(Figure 3). The fact that Psd1 causes a substantially lower
decrease on the stiffness of1gcs cells surface (34%) can be related
with the strong evidence that this defensin has glucosylceramide
as a molecular target in C. albicans cell membrane, as previously
suggested (de Medeiros et al., 2010, 2014; Gonçalves et al.,
2012; Rollin-Pinheiro et al., 2016). The AMPH B-driven strong
reduction of 1gcs cells’ stiffness (60%, Figure 3) may be due to
a synergistic effect between the pores formed by this antifungal
drug at cell surface and the lack of GlcCer in the cell membrane.
As the binding of AMPH B to ergosterol is irreversible (Filippin
et al., 2008), together with GlcCer absence in C. albicans cells,
there is no way for the cell to repair the damage caused by
antifungal action in the cell surface, becoming unstable and with
a lower resistance (Leipelt et al., 2001).
Looking at AFM phase contrast images of C. albicans after
treatment with Psd1 (Figure S7), it was possible to observe softer
domains on its surface, which coincide with the localization of
blebs seen in error signal images. These softer areas are probably
an effect due to the accumulation of the peptide on the cell
surface, eventually acting in a detergent-like manner, leading to a
disorganization and micellization of the lipids and, consequently,
to unstable cell membrane and wall.
The ability of an antimicrobial peptide to induce cell death
is associated with the mechanism by which it acts against its
target(s), often at the level of the cell wall and/or membrane. The
importance of the type of membrane that the peptide finds is
significant; thus, differences between strains would be expected.
For CI cells, none of the molecules tested here (AMPH B, FCZ,
and Psd1) caused a significant loss of viability (Figures 4B,C
and Figure S3), which could only be explained by the mode of
action of the peptide in these cells. Even in themembrane, patient
cells could have some small biochemical changes in the GlcCer
molecules or on the orientation in the membrane, affecting the
mechanism of action of the peptide (Rollin-Pinheiro et al., 2016).
Although, it was clear from other results that the peptide acts in
these type of cells, reducing the roughness and stiffness of the cells
(Figures 2, 3, respectively), it is not mandatory to this AMP to
induce death or to permeabilize the cell membrane, explaining
why there is no positive results for dead cells.
Psd1 had a stronger effect on WT C. albicans than the
conventional antifungal molecules (AMPH B and FCZ),
independently of the concentration used. Aditionally, it was
notable that the percentage of dead cells was higher for WT
than 1gcs cells (Figures 4D,F,H,I) (de Medeiros et al., 2014).
The lack of GlcCer in the membrane of 1gcs cells could explain
previous observations regarding this lipid, as it plays an essential
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role in fungal virulence (Thevissen et al., 2003, 2012; Barreto-
Bergter et al., 2004). Although, it is not clear which mechanism
predominates for each strain, the reported explanations of
the mode of action of individual defensins include binding to
the cell wall, induction of signaling cascades and interaction
with intracellular targets, leading to apoptosis, membrane
permeabilization and receptor-mediated internalization
(Thevissen et al., 2004; de Medeiros et al., 2010; Van Der
Weerden et al., 2013). Considering that Psd1 interacts with N.
crassa cell cycle protein cyclin F and halts the cell cycle (Lobo
et al., 2007), recently, the same has been reported for C. albicans,
entering in the cells and interacting with an intracellular target,
leading to cell death (de Medeiros et al., 2014).
We believe that Psd1 first acts at the fungal wall level,
disaggregating the polysaccharide matrix and disturbing the
wall, composed by mannoproteins, β-glucans, and chitin. This
affects the integrity of the cell wall by increasing cell roughness
and decreasing its rigidity. When the peptide reaches the cell
membrane, it interacts with glucosylceramides in the C. albicans
membrane and induces an intracellular effect. Later on, the
intracellular accumulation of Psd1 interferes with the cell cycle
control protein cyclin F, as previously described for C. albicans
(de Medeiros et al., 2014), in a similar way to what was found
for N. crassa (Lobo et al., 2007), which leads to apoptosis of the
fungal pathogen.
The ability of planktonic cells to adhere to an abiotic surface
and to other cells is an important virulence factor, and it is
especially important for biofilm formation. By hindering this
ability, Psd1 testing against C. albicans biofilms becomes highly
relevant. Biofilms exhibit increased drug resistance compared
to planktonic cells (Figures 1, 5, respectively). Changes in
the mode of action of some antifungic molecules vary from
planktonic to sessile cell states (biofilm). This is true for AMPH
B, FCZ, and Psd1 on C. albicans biofilms (Figures 5, 6). The
complex structure of the biofilm, surrounded by substances
rich in exopolymers, with high components of carbohydrates,
proteins, hexosamines, phosphorus and uric acid, may restrict the
penetration of external agents, decreasing their effects (Figures 5,
6) and increasing biofilm life-time.
This work elucidates some aspects of the Pisum sativum
defensin 1 antifungal activity that had not been previously
investigated. By hindering cells ability to adhere, Psd1 may also
contribute to preventing an infection to proliferate, by reducing
the adherence of C. albicans cells to the infected tissue. It is
also possible to consider that Psd1 may interfere with biofilm
formation, which depends highly on cell-substrate and cell-cell
adherence (Alsteens et al., 2013a,b), as well as on quorum sensing
(Kruppa, 2009). Altogether, the ability of morphological forms
(fungal pleomorphism) of C. albicans was interfered by Psd1
(Figures 1, 5).
The molecular design and synthesis of newmolecules inspired
on AMPs structure and sequence seem to be a promising
approach to open a new and extensive field of applications
(Oren et al., 1997; Wu et al., 2003; McPhee et al., 2005),
ranging from antimicrobial therapy, to their possible use as
vaccine adjuvants. Therefore, a better understanding of function
and mechanism of action of host defense peptides is a great
promise in anti-infective and immunomodulatory therapeutics.
Our previous work showed that Psd1 interacts with membranes
which composition mimicking fungal membranes (Gonçalves
et al., 2012). Strong interactions with ergosterol and GlcCer-
containing membranes were reported, while no interaction with
cholesterol-containing membranes justifies a reduced toxicity to
mammalian cells (with cholesterol-rich membranes). Here, we
show that Psd1 has a strong and pleiotropic antifungal activity
on C. albicans, and the importance of GlcCer as a key component
of fungal membranes was underlined.
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